Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Biomarker and diagnostic research for atypical hemolytic-uremic syndrome with anti-factor H antibodies has been reported in the published literature.
No clinical trials have been registered for atypical hemolytic-uremic syndrome with anti-factor H antibodies.
20 publications have been identified in PubMed for atypical hemolytic-uremic syndrome with anti-factor H antibodies. Research spans Case Report / Case Series (50%), Review / Meta-Analysis (15%), and Clinical Trial Publication (15%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 10 | 50% |
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 5:38 PM UTC
Patient Advocacy Groups (PAGs) provide support, resources, and community for patients and caregivers.
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about atypical hemolytic-uremic syndrome with anti-factor H antibodies
Research summaries |
3 |
15% |
Clinical study results | 3 | 15% |
Other research | 1 | 5% |
Testing and diagnosis research | 1 | 5% |
Laboratory research | 1 | 5% |
Disease patterns and progression | 1 | 5% |
Sinha A (2026). [PMID: 42101481](https://pubmed.ncbi.nlm.nih.gov/42101481/). *Pediatr Nephrol*. [Review / Meta-Analysis]
Mancianti N (2026). [PMID: 41857696](https://pubmed.ncbi.nlm.nih.gov/41857696/). *BMC Nephrol*. [Case Report / Case Series]
Zhang YX (2026). [PMID: 41986268](https://pubmed.ncbi.nlm.nih.gov/41986268/). *Zhonghua Er Ke Za Zhi*. [Clinical Trial Publication]
Gupta M (2026). [PMID: 41874691](https://pubmed.ncbi.nlm.nih.gov/41874691/). *Pediatr Nephrol*. [Case Report / Case Series]
Hasvi J (2025). [PMID: 40443860](https://pubmed.ncbi.nlm.nih.gov/40443860/). *Oxf Med Case Reports*. [Case Report / Case Series]
Alyamany R (2025). [PMID: 41613109](https://pubmed.ncbi.nlm.nih.gov/41613109/). *Front Immunol*. [Review / Meta-Analysis]
Nugteren S (2025). [PMID: 40118156](https://pubmed.ncbi.nlm.nih.gov/40118156/). *Immunol Lett*. [Review / Meta-Analysis]
Coccia PA (2025). [PMID: 39379643](https://pubmed.ncbi.nlm.nih.gov/39379643/). *Pediatr Nephrol*. [Case Report / Case Series]
Pattonieri EF (2025). [PMID: 39997466](https://pubmed.ncbi.nlm.nih.gov/39997466/). *Infect Dis Rep*. [Case Report / Case Series]
He WY (2025). [PMID: 40484823](https://pubmed.ncbi.nlm.nih.gov/40484823/). *Zhonghua Nei Ke Za Zhi*. [Case Report / Case Series]